查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年鼻扩张器的全球市场
市场调查报告书
商品编码
1217595

2022-2029 年鼻扩张器的全球市场

Global Internal Nasal Dilators Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

鼻孔扩张器是一种插入鼻孔的装置，可帮助扩张鼻道并改善呼吸。 如果您因鼻息肉、鼻中隔偏曲或过敏等情况而出现鼻塞，它可能有助于缓解鼻塞并改善气流。 有几种类型的鼻孔扩张器，包括弹簧装置、胶条和硅胶塞。 与其他治疗选择（例如喷鼻剂和口服药物）一起，这些设备可以帮助控制鼻塞症状。

市场动态

全球鼻扩张器市场的增长受到以下因素的推动：技术进步、鼻部疾病患病率上升、对鼻部疾病的认识提高、鼻部手术增多、生活方式改变和空气污染加剧、医疗成本上升和转向家庭护理。

打鼾和阻塞性睡眠呼吸暂停 (OSA) 疾病的患病率上升推动了市场增长

打鼾和阻塞性睡眠呼吸暂停 (OSA) 会导致白天过度嗜睡、机动车事故风险增加以及多种心血管和神经血管并发症。. 根据美国胸科学会 2020 年发表的一篇论文，阻塞性睡眠呼吸暂停 (OSA) 影响了全球 9.36 亿 30 至 69 岁的成年人，其中约 4.25 亿人患有中度疾病。估计患有中度至重度疾病。 在美国，据保守估计，6% 的女性和 13% 的男性患有具有临床意义的 OSA，定义为 15 次或更多事件的呼吸暂停低通气指数 (AHI)。 OSA 会留下严重的神经认知和心血管后遗症，并且难以进行最佳治疗。

鼻扩张器也被建议用于阻塞性睡眠呼吸暂停综合征 (OSAS) 患者。 OSAS 是一种常见的睡眠障碍，具有严重的公共卫生后果。 几项随机对照试验证明，持续气道正压通气 (CPAP) 被认为是中度至重度 OSAS 患者的主要药物治疗。

鼻扩张器价格高阻碍市场增长

但是，某些鼻扩张器的高价格可能成为一些人的障碍并限制了他们的采用。 鼻扩张器的价格会因设备的类型和品牌而有很大差异。 有些很便宜，有些很贵。 例如，一包自粘式鼻孔扩张器的价格可能不到 10 美元，而仅需处方的弹簧式鼻孔扩张器可能要花费数百美元。 这些高昂的成本可能使一些人难以购买，尤其是购买没有保险或免赔额高的设备。 此外，除了高成本之外，重要的是要指出保险公司缺乏报销是影响鼻扩张器市场的一个因素。 这对製造商和消费者都是一个挑战。 这对生产商和消费者来说都很难。 这可能会限制其使用，因为个人可能会选择保险涵盖的更便宜的治疗方案。

COVID-19 影响分析

COVID-19 疫情对鼻扩张器市场产生了重大影响。 这些设备用于治疗鼻塞和其他呼吸系统问题，但由于大流行，需求有所增加。 COVID-19 可引起鼻塞等呼吸道症状，这可能导致对缓解这些症状的产品的需求增加。 此外，许多人由于大流行的影响而感到焦虑和压力，这可能会导致鼻塞。 此外，随着远程工作和远程医疗在许多国家变得越来越普遍，越来越多的人正在寻求家庭护理来治疗鼻塞等呼吸系统疾病。 对此类家庭治疗的需求不断增长，也推动了对口腔鼻扩张器的需求。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 对可定制和可重复使用的鼻内扩张器的需求不断增加
      • 打鼾和阻塞性睡眠呼吸暂停 (OSA) 疾病的患病率增加
    • 约束因素
      • 设备成本高
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 罗纹类型
  • 平滑型

第 8 章使用

  • 重用
  • 一次性使用

第9章材料

  • 聚合物
  • 聚合物+合金
  • 其他

第 10 章应用

  • 打鼾
  • 鼻中隔偏斜
  • 鼻窦炎
  • 睡眠呼吸暂停综合症
  • 其他

第 11 章按销售渠道

  • 医院药房
  • 零售药房
  • 在线药店

第12章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第13章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 按类型划分的基准

第14章公司简介

  • Rhinomed 有限公司
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Splintek Inc
  • Nasanita
  • SHREYAAS HEALTH CARE PVT LTD
  • Scandinavian Formulas
  • Tomed GmbH
  • Nasilator
  • HealthRight Products, LLC
  • SIBEL, S.A.U.
  • GlaxoSmithKline

第15章 DataM

简介目录
Product Code: DMMD1439

Market Overview

The global internal nasal dilators market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Internal nasal dilators are devices inserted into the nostrils to help expand the nasal passages and improve breathing. They can help alleviate nasal congestion and improve airflow in people with nasal obstruction caused by conditions such as nasal polyps, deviated septum, or allergies. Several types of internal nasal dilators are available, including spring-loaded devices, adhesive strips, and silicone plugs. These devices can be used with other treatment options, such as nasal sprays or oral medications, to help manage symptoms of nasal obstruction.

Market Dynamics

The global internal nasal dilators market growth is driven by technological advancements, the rising prevalence of nasal disorders, increasing awareness of nasal disorders, the growing number of nasal surgery, changing lifestyles and increasing air pollution, increased healthcare expenditure, and a shift in focus towards home-based treatments.

An increasing prevalence of Snoring and obstructive sleep apnea (OSA) diseases drives the market growth

Snoring and obstructive sleep apnea (OSA) can induce excessive daytime sleepiness, increased risk of car accidents, and several cardiovascular and neurovascular medical complications. As per the article published in the American Thoracic Society in 2020, Obstructive sleep apnea (OSA) affects an estimated 936 million adults 30-69 years old worldwide, with approximately 425 million adults experiencing moderate to severe disease. In the U.S., conservative estimates suggest that 6% of women and 13% of men have clinically significant OSA, defined as an apnea-hypopnea index (AHI) of 15 events or greater. OSA has major neurocognitive and cardiovascular sequelae, but optimal treatment can be challenging.

Nasal dilators have also been proposed in patients with obstructive sleep apnea syndrome (OSAS). OSAS is a prevalent sleep disorder with significant public health outcomes. Continuous positive airway pressure (CPAP) is considered the primary medical treatment for patients with moderate to severe OSAS, as evidenced by several randomized controlled trials.

High cost of internal nasal dilators will hamper the growth of the market

However, the high cost of some internal nasal dilators can be a barrier for some individuals and may limit their adoption. Prices for internal nasal dilators can vary widely, depending on the type of device and the brand. Some internal nasal dilators can be inexpensive, while others can be quite costly. For example, a pack of adhesive nasal strips may cost less than $10, while a prescription-only, spring-loaded nasal dilator can cost several hundred dollars. These high costs may make it difficult for some individuals to afford the devices, especially those without insurance coverage or with high deductibles. Additionally, to the high cost, it is important to mention the lack of reimbursement by the insurance company as a factor that will impact on internal nasal dilator market; this can be challenging for both manufacturers and consumers. This can limit their use, as individuals may opt for cheaper treatment options covered by their insurance.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the market for internal nasal dilators. These devices are used to treat nasal congestion and other breathing-related issues, and demand for them has increased due to the pandemic. One reason is that COVID-19 can cause respiratory symptoms such as nasal congestion, which has increased demand for products that can help alleviate these symptoms. Additionally, many people have been experiencing anxiety and stress related to the pandemic, which can cause nasal congestion. Moreover, many countries have seen an increase in remote working and telemedicine, leading to more people seeking treatment for nasal congestion and other breathing issues from their homes. This increased demand for at-home treatments has also helped boost demand for internal nasal dilators.

Segment Analysis

The sleep apnea segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The sleep apnea segment accounts for the highest market share. The nasal valve area has a minimal cross-sectional area of the upper airways. Obstructive sleep apnea syndrome (OSAS) is a common disorder. It has been reported that nasal obstruction may be associated with OSAS.

McKeon Products offers AIRMAX Nasal Dilator for Better Sleep - Two Size Trial Pack - (Small and Medium - Clear), a simple solution for individuals who have sleeping and breathing difficulties; designed to be comfortably placed inside the nasal passages - it is patented, aerodynamic winged design is clinically proven to help improve airflow by expanding the nasal passages, Clinically proven to help reduce snoring and mild sleep apnea. To relieve nasal congestion, An FDA cleared medical device made of hypoallergenic, medical grade material that is soft, flexible and comfortable; more effective than Breathe Right Nasal Strips, Available in medium (fits most) and small, and includes a carrying case and A patented design.

Geographical Analysis

North America region holds the largest market share of the global Internal Nasal Dilators market

North America dominates the market for internal nasal dilators and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of nasal disorders, and product launches by market players in the North American region drive the market.

Sinusitis is one of the most common chronic conditions in the United States, affecting fifty million Americans, 20% of the nation's population. Sinusitis is a chronic (ongoing) disease that includes the symptoms of nasal obstruction (difficulty breathing through the nose), nasal drainage, decreased sense of smell, facial pressure, and frequent sinus infections.

As per the UCI Health, Nose and sinus disorders afflict millions of people, causing pain, fatigue, headache, breathing difficulties and loss of smell, among other symptoms. Sinusitis alone affects about 37 million people at least once yearly, making it one of the most common illnesses in the United States.

Competitive Landscape

The internal nasal dilators market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Rhinomed Limited, Splintek Inc, Nasanita, SHREYAAS HEALTH CARE PVT LTD, Scandinavian Formulas, Airware Labs, Tomed GmbH, Nasilator, HealthRight Products, LLC, SIBEL, S.A.U., and GlaxoSmithKline plc, among others. The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the internal nasal dilators market globally.

Rhinomed Limited

Overview:

Rhinomed is an airway technology organization that seeks to improve how you breathe radically, sleep, maintain your health and take medication. Rhinomed's patented nasal technology leverages the physiology of the nose to optimize our breathing which is essential to restful sleep and maintaining good health.

Product Portfolio:

MUTE TRIAL PACK: A nasal breathing device called Mute softly opens your airways to boost airflow via your nose as you sleep.

The global internal nasal dilators market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Customized and Reusable Internal Nasal Dilators
      • 4.1.1.2. An increasing prevalence of Snoring and obstructive sleep apnea (OSA) diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Ribbed Type*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Smooth

8. By Usability

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 8.1.2. Market Attractiveness Index, By Usability
  • 8.2. Reusable*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Single Use

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Polymer*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Polymer + Alloy
  • 9.4. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Snoring*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Deviated Septum
  • 10.4. Sinusitis
  • 10.5. Sleep Apnea
  • 10.6. Others

11. By Distribution Channel

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2. Market Attractiveness Index, By Distribution Channel
  • 11.2. Hospitals Pharmacies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Retail Pharmacies
  • 11.4. Online Pharmacies

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Usability
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Type Benchmarking

14. Company Profiles

  • 14.1. Rhinomed Limited*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Splintek Inc
  • 14.3. Nasanita
  • 14.4. SHREYAAS HEALTH CARE PVT LTD
  • 14.5. Scandinavian Formulas
  • 14.6. Tomed GmbH
  • 14.7. Nasilator
  • 14.8. HealthRight Products, LLC
  • 14.9. SIBEL, S.A.U.
  • 14.10. GlaxoSmithKline

LIST NOT EXHAUSTIVE

15. Global Internal Nasal Dilators Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us